Cancer Causes & Control; Lerro, C. et. al.
Feb 24th, 2019 - To evaluate cancer incidence in the Agricultural Health Study (AHS), a cohort of private pesticide applicators, their spouses, and commercial applicators, based on 12,420 cancers, adding 5,989 cancers, and 9 years of follow-up since last evaluation. Overall AHS cancer incidence was lower than the general population (SIRprivate = 0.91, CI 0.89–0.93; SIRspouse = 0.89, CI 0.86–0.92; SIRcommercial ...
Aug 29th, 2019 - Guidelines on the diagnosis, staging, and treatment of testicular cancer were released in July 2019 by the European Association of Urology. Diagnosis and Staging Recommendations Sperm banking should be discussed with all men before embarking on treatment for testicular cancer. Testicular ultrasonography should be performed on all patients in whom testicular cancer is suspected. In patients a...
Jul 3rd, 2019 - Systemic Chemotherapy Except for the single-agent carboplatin, most chemotherapy regimens used to treat testicular cancer are combinations of 2 or more chemotherapy agents. For this review, we will focus on the 3 most commonly used regimens: bleomycin, etoposide, and cisplatin (BEP), etoposide and cisplatin (EP), and etoposide, ifosfamide, and cisplatin (VIP).
Mar 4th, 2019 - Delaying antibiotics in elderly patients with urinary tract infections is linked to higher sepsis, death rates. A pilot study of smartphone-based visual tests shows promise in multiple sclerosis.
Andrew D. Bowser
Mar 1st, 2019 - Adjuvant treatments appear to have no significant detrimental long-term effects on sperm count in men being treated for clinical stage I testicular cancer, results of a recent investigation suggest. Sperm number and concentration were largely stable over time in patients who received a round of chemotherapy or radiation to lymph nodes following orchiectomy, according to results of the 182-patie.
Pediatric News; Francine Pearce, MD
Nov 28th, 2018 - Testicular cancer is noted to be the most common malignant cancer among men aged 15-44 years. 1 Despite its being the most common, studies show testicular cancer accounts for only 1% of cancers among men over all.
Aug 15th, 2018 - The American Academy of Family Physicians (AAFP) no longer recommends pelvic examinations in asymptomatic women unless needed for guideline-appropriate cervical cancer screening, according to its newest Choosing Wisely list, released online August 8. This is the AAFP's fourth set of Choosing Wisely recommendations, which also address daily home glucose monitoring in patients with type 2 diabete...
Jul 2nd, 2018 - Patients with painful testicular lumps or swelling should be referred urgently by their GP to a specialist as the symptoms are strongly associated with testicular cancer, a UK study found. The research, published in the British Journal of General Practice, found that painful testicular enlargement was a major risk factor for the disease, contrary to traditional understanding. The study by Dr El...
Jan 20th, 2018 - The first time Dave Fuehrer was diagnosed with testicular cancer, he was knocked back. The twenty-something competitive bodybuilder, a recent New York State champion, was unprepared for his journey from wellness to disease, and then through treatments and their sequelae.
Oct 9th, 2017 - Urgent action is required to identify the causes of the substantial reductions in sperm counts that have occurred over the past 3 decades in men in the developed world to avert a future crisis, says an expert writing in the BMJ. Niels Skakkebaek, professor of pediatric endocrinology and andrology, Rigshospitalet, University of Copenhagen, Denmark, notes that, when coupled with data showing that...
Jun 14th, 2017 - CHICAGO – Hypogonadism may compromise the long-term health outlook for many younger men who have been successfully treated for testicular cancer, according to an analysis conducted by the Platinum Study Group. “Today, 95% of all testicular cancer patients are cured of their disease thanks to cisplatin-based chemotherapy.
Jun 3rd, 2017 - CHICAGO – More than one-third of testicular cancer survivors have hypogonadism, according to an analysis of nearly 500 male patients conducted by the Platinum Study Group. Lead author Mohammad Abu Zaid, MBBS, of Indiana University, Indianapolis, discusses the implications for long-term health, screening during follow-up, testing, and testosterone replacement therapy in a video interview at the.
Jun 1st, 2017 - CHICAGO — A substantial percentage of testicular cancer survivors have low testosterone levels, which in turn puts them at risk for a plethora of chronic health conditions, including hypertension, diabetes, erectile dysfunction, anxiety, and depression, according to findings from a large multicenter study. For example, compared to survivors with normal testosterone levels, those with hypogonadi...
Mar 28th, 2017 - In what is thought to be the first study to look at cancer-specific mortality among patients with learning difficulties, British researchers found a four-fold higher death rate from testicular cancer in this group when compared with the general population. The team is now studying other types of cancer, and lead author, Mehran Afshar, MBBS, PhD, from St George's Hospital, London, United Kingdom...
BY DAMIAN MCNAMARA
Feb 23rd, 2017 - ORLANDO – Although two cycles of bleomycin-etoposide-cisplatin (BEP) chemotherapy typically comprise adjuvant treatment for nonseminomatous or combined germ cell testicular cancer, investigators suggest one cycle may be sufficient. “Over recent years, evidence has begun to accumulate that one single cycle of BEP may be sufficient to reduce the recurrence rate to below 5%,” said Robert Anthony H.
Jan 29th, 2017 - SAN DIEGO, California ― Testicular cancer is associated with an excellent prognosis, but survivors face a worrisome risk of developing certain metabolic effects, such as hypertension, that are tied to platinum-based chemotherapy, according to new findings. In the study, 1 in 5 testicular cancer survivors who were treated with this chemotherapy developed metabolic syndrome, which is associated w...
Jan 5th, 2017 - (Reuters) - A U.S. jury in Ohio ordered DuPont on Thursday to pay $10.5 million in punitive damages to a man who said he developed testicular cancer from exposure to a toxic chemical leaked from a Dupont plant, the plaintiff’s lawyer Robert Bilott said. The Dupont logo is displayed on a board above the floor of the New York Stock Exchange shortly after the opening bell in New York, U.S. on Dece...
Aug 10th, 2016 - Testicular cancer is a disease of young men, primarily diagnosed in their 20s and early 30s, and is highly curable. But according to new research, the use of psychotropic and stimulant medications (PSMs) is high in the survivor population. In a cohort of 680 testicular cancer survivors, 12.5% reported using PSMs. "Women are more likely to use psychotropic drugs. If you have this many men usi...
Jul 8th, 2016 - NEW YORK (Reuters) - U.S. jurors ordered DuPont on Friday to pay an additional $500,000 in punitive damages to a man who said he developed testicular cancer from exposure to a toxic chemical used to make Teflon at one of its plants, according to a lawyer for the plaintiff. A view of the Dupont logo on a sign at the Dupont Chestnut Run Plaza facility near Wilmington, Delaware, in this April 17, ...
Jul 7th, 2016 - Action Points Note that this study of testicular cancer survivors who received cisplatin chemotherapy showed a significant rate of hearing loss. Interestingly, hearing loss was associated with other markers of morbidity such as hypertension. Survivors of adult-onset testicular cancer given cisplatin (Platinol, Platinol-AQ) should undergo routine hearing exams and hypertension control and warned...